Up to date, current standard care only provides disease symptom management for Parkinson's disease and related dementia patients, and does not address to close the urgent medical necessity gap for these patients. We are a startup pharmacology company dedicated to developing safe, and non invasive innovative therapeutic technology,and pipelines able to disease modify Parkinson's disease motor symptoms, or, and non motor symptoms including cognitive decline, Lewbody dementia, and brain neurodegeneration.
Nevada Center for Applied Research
Applied Research Facility
University of Nevada, Reno MS 0525